Vincerx Pharma, Inc. Common Stock (VINC)

Vincerx Pharma, Inc. Common Stock (VINC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $68,045; returns 1 day +0.0%.

Vincerx Pharma Inc. (VINC) is a clinical-stage biopharmaceutical company that, in early 2025, shifted from active drug development to asset monetization and dissolution. The company's initial focus was on developing novel cancer therapeutics, including antibody-drug conjugates (ADCs) and small molecule drug conjugates, utilizing their VersAptx bioconjugation platform.

Groups VINC belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Oncology
• Cancer Therapeutics
• Antibody-Drug Conjugates
• Biopharmaceutical
• Life Sciences

VINC financial model: income statement, cash flow and balance sheet